Autoinflammatory Bone Diseases

Rheumatic Disease Clinics of North America

Volumn 39, Issue 4, 2013, Pages 735-749

  Stern, Sara M ^a   Ferguson, Polly J ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Autoinflammatory bone diseases; Cherubism; Chronic nonbacterial osteomyelitis; CRMO; DIRA; Majeed syndrome; SAPHO syndrome

Indexed keywords

BINDING PROTEIN; BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID; GAMMA INTERFERON; INDOMETACIN; INTERLEUKIN 10; METHOTREXATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; SH3 BINDING PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

AUTOINFLAMMATORY DISEASE; BONE DISEASE; CAUSAL ATTRIBUTION; CHROMOSOME 18Q; CHRONIC OSTEOMYELITIS; CLINICAL FEATURE; DEFICIENCY OF INTERLEUKIN 1 RECEPTOR ANTAGONIST; DISEASE ACTIVITY; DRUG SAFETY; FIBROUS DYSPLASIA; GENE MUTATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; ILIRN GENE; IMMUNOPATHOLOGY; INFLAMMATION; JUVENILE MANDIBULAR CHRONIC OSTEOMYELITIS; LPIN2 GENE; MAJEED SYNDROME; MUTATOR GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROPIONIBACTERIUM ACNES; PSTPIP2 GENE; REVIEW; SAPHO GENE; SAPHO SYNDROME; UNSPECIFIED SIDE EFFECT;

AUTOINFLAMMATORY BONE DISEASES; CHERUBISM; CHRONIC NONBACTERIAL OSTEOMYELITIS; CRMO; DIRA; MAJEED SYNDROME; SAPHO SYNDROME;

ACNE VULGARIS; ACQUIRED HYPEROSTOSIS SYNDROME; ANEMIA, DYSERYTHROPOIETIC, CONGENITAL; BONE DISEASES; CHERUBISM; CHRONIC DISEASE; HEREDITARY AUTOINFLAMMATORY DISEASES; HUMANS; HYPEROSTOSIS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; OSTEITIS; OSTEOMYELITIS; SYNDROME; SYNOVITIS;

EID: 84886798408     PISSN: 0889857X     EISSN: 15583163     Source Type: Journal    
DOI: 10.1016/j.rdc.2013.05.002     Document Type: Review

References (73)

1. Masters S.L., Simon A., Aksentijevich I., et al. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). Annu Rev Immunol 2009, 27:621-668.
2. Jansson A., Renner E.D., Ramer J., et al. Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford) 2007, 46:154-160.
3. Girschick H.J., Zimmer C., Klaus G., et al. Chronic recurrent multifocal osteomyelitis: what is it and how should it be treated?. Nat Clin Pract Rheumatol 2007, 3:733-738.
4. Jansson A.F., Müller T.H., Gliere L., et al. Clinical score for nonbacterial osteitis in children and adults. Arthritis Rheum 2009, 60:1152-1159.
5. Borzutzky A., Stern S., Reiff A., et al. Pediatric chronic nonbacterial osteomyelitis. Pediatrics 2012, 130:e1190-e1197.
6. Catalano-Pons C., Comte A., Wipff J., et al. Clinical outcome in children with chronic recurrent multifocal osteomyelitis. Rheumatology (Oxford) 2008, 47:1397-1399.
7. Giedion A., Holthusen W., Masel L.F., et al. Subacute and chronic "symmetrical" osteomyelitis. Ann Radiol (Paris) 1972, 15:329-342.
8. Probst F.P., Bjorksten B., Gustavson K.H. Radiological aspect of chronic recurrent multifocal osteomyelitis. Ann Radiol (Paris) 1978, 21:115-125.
9. Girschick H.J., Raab P., Surbaum S., et al. Chronic non-bacterial osteomyelitis in children. Ann Rheum Dis 2005, 64:279-285.
10. Gikas P.D., Islam L., Aston W., et al. Nonbacterial osteitis: a clinical, histopathological, and imaging study with a proposal for protocol-based management of patients with this diagnosis. JOrthop Sci 2009, 14:505-516.
11. Beretta-Piccoli B.C., Sauvain M.J., Gal I., et al. Synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome in childhood: a report of ten cases and review of the literature. Eur J Pediatr 2000, 159:594-601.
12. Schilling F., Wagner A.D. Azithromycin: an anti-inflammatory effect in chronic recurrent multifocal osteomyelitis? A preliminary report. ZRheumatol 2000, 59:352-353.
13. Edlund E., Johnsson U., Lidgren L., et al. Palmoplantar pustulosis and sternocostoclavicular arthro-osteitis. Ann Rheum Dis 1988, 47:809-815.
14. Hofmann S.R., Schwarz T., Möller J.C., et al. Chronic non-bacterial osteomyelitis is associated with impaired Sp1 signaling, reduced IL10 promoter phosphorylation, and reduced myeloid IL-10 expression. Clin Immunol 2011, 141:317-327.
15. Hofmann S.R., Morbach H., Schwarz T., et al. Attenuated TLR4/MAPK signaling in monocytes from patients with CRMO results in impaired IL-10 expression. Clin Immunol 2012, 145:69-76.
16. Hofmann S.R., Roesen-Wolff A., Hahn G., et al. Update: cytokine dysregulation in chronic nonbacterial osteomyelitis (CNO). Int J Rheumatol 2012, 2012:310206.
17. Ferguson P.J., Chen S., Tayeh M.K., et al. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). JMed Genet 2005, 42:551-557.
18. Aksentijevich I., Masters S.L., Ferguson P.J., et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. NEngl J Med 2009, 360:2426-2437.
19. Reddy S., Jia S., Geoffrey R., et al. An autoinflammatory disease due to homozygous deletion of the IL1RN locus. NEngl J Med 2009, 360:2438-2444.
20. Ferguson P.J., Bing X., Vasef M.A., et al. Amissense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis. Bone 2006, 38:41-47.
21. Grosse J., Chitu V., Marquardt A., et al. Mutation of mouse Mayp/Pstpip2 causes a macrophage autoinflammatory disease. Blood 2006, 107:3350-3358.
22. Yeung Y.G., Soldera S., Stanley E.R. Anovel macrophage actin-associated protein (MAYP) is tyrosine-phosphorylated following colony stimulating factor-1 stimulation. JBiol Chem 1998, 273:30638-30642.
23. Wu Y., Dowbenko D., Lasky L.A. PSTPIP 2, a second tyrosine phosphorylated, cytoskeletal-associated protein that binds a PEST-type protein-tyrosine phosphatase. JBiol Chem 1998, 273:30487-30496.
24. Shoham N.G., Centola M., Mansfield E., et al. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci USA 2003, 100:13501-13506.
25. Golla A., Jansson A., Ramser J., et al. Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3-18q22. Eur J Hum Genet 2002, 10:217-221.
26. Beck C., Morbach H., Beer M., et al. Chronic nonbacterial Osteomyelitis in childhood: prospective follow-up during the first year of anti-inflammatory treatment. Arthritis Res Ther 2010, 12:R74.
27. Morbach H., Dick A., Beck C., et al. Association of chronic non-bacterial osteomyelitis with Crohn's disease but not with CARD15 gene variants. Rheumatol Int 2010, 30:617-621.
28. Khanna G., Sato T.S., Ferguson P. Imaging of chronic recurrent multifocal osteomyelitis. Radiographics 2009, 29:1159-1177.
29. Mandell G.A., Contreras S.J., Conard K., et al. Bone scintigraphy in the detection of chronic recurrent multifocal osteomyelitis. JNucl Med 1998, 39:1778-1783.
30. Wipff J., Adamsbaum C., Kahan A., et al. Chronic recurrent multifocal osteomyelitis. Joint Bone Spine 2011, 78:555-560.
31. Fritz J., Tzaribatchev N., Claussen C.D., et al. Chronic recurrent multifocal osteomyelitis: comparison of whole-body MR imaging with radiography and correlation with clinical and laboratory data. Radiology 2009, 252:842-851.
32. Jurik A.G., Egund N. MRI in chronic recurrent multifocal osteomyelitis. Skeletal Radiol 1997, 26:230-238.
33. Guérin-Pfyffer S., Guillaume-Czitrom S., Tammam S., et al. Evaluation of chronic recurrent multifocal osteitis in children by whole-body magnetic resonance imaging. Joint Bone Spine 2012, 79:616-620.
34. Sato T.S., Ferguson P.J., Khanna G. Primary multifocal osseous lymphoma in a child. Pediatr Radiol 2008, 38:1338-1341.
35. Ferguson P.J., El-Shanti H.I. Autoinflammatory bone disorders. Curr Opin Rheumatol 2007, 19:492-498.
36. Abril J.C., Ramirez A. Successful treatment of chronic recurrent multifocal osteomyelitis with indomethacin: a preliminary report of five cases. JPediatr Orthop 2007, 27:587-591.
37. Twilt M., Laxer R.M. Clinical care of children with sterile bone inflammation. Curr Opin Rheumatol 2011, 23:424-431.
38. Eleftheriou D., Gerschman T., Sebire N., et al. Biologic therapy in refractory chronic non-bacterial osteomyelitis in childhood. Rheumatology (Oxford) 2010, 49:1505-1512.
39. Deutschmann A., Mache C.J., Bodo K., et al. Successful treatment of chronic recurrent multifocal Osteomyelitis with tumor necrosis factor-alpha blockage. Pediatrics 2005, 116:1231-1233.
40. Marangoni R.G., Halpern A.S. Chronic recurrent multifocal osteomyelitis primarily affecting the spine treated with anti-TNF therapy. Spine (Phila Pa 1976) 2010, 35:E253-E256.
41. Simm P.J., Allen R.C., Zacharin M.R. Bisphosphonate treatment in chronic recurrent multifocal osteomyelitis. JPediatr 2008, 152:571-575.
42. Gleeson H., Wiltshire E., Briody J., et al. Childhood chronic recurrent multifocal osteomyelitis: pamidronate therapy decreases pain and improves vertebral shape. JRheumatol 2008, 35:707-712.
43. Miettunen P.M., Wei X., Kaura D., et al. Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J 2009, 7:2.
44. Hospach T., Langendoerfer M., von Kalle T., et al. Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate. Eur J Pediatr 2010, 169:1105-1111.
45. Majeed H.A., Kalaawi M., Mohanty D., et al. Congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with Sweet syndrome in two siblings. JPediatr 1989, 115:730-734.
46. Majeed H.A., Al-Tarawna M., El-Shanti H., et al. The syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia. Report of a new family and a review. Eur J Pediatr 2001, 160:705-710.
47. Ferguson P.J., Sandu M. Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis. Curr Rheumatol Rep 2012, 14:130-141.
48. Al-Mosawi Z.S., Al-Saad K.K., Ijadi-Maghsoodi R., et al. Asplice site mutation confirms the role of LPIN2 in Majeed syndrome. Arthritis Rheum 2007, 56:960-964.
49. Donkor J., Zhang P., Wong S., et al. Aconserved serine residue is required for the phosphatidate phosphatase activity but not the transcriptional coactivator functions of lipin-1 and lipin-2. JBiol Chem 2009, 284:29968-29978.
50. Donkor J., Sariahmetoglu M., Dewald J., et al. Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. JBiol Chem 2007, 282:3450-3457.
51. Herlin T., Fiirgaard B., Bjerre M., et al. Efficacy of anti-IL-1 treatment in Majeed syndrome. Ann Rheum Dis 2013, 72:410-413.
52. Valdearcos M., Esquinas E., Meana C., et al. Lipin-2 reduces proinflammatory signaling induced by saturated fatty acids in macrophages. JBiol Chem 2012, 287:10894-10904.
53. Jesus A.A., Osman M., Silva C.A., et al. Anovel mutation of IL1RN in the deficiency of interleukin-1 receptor antagonist syndrome: description of two unrelated cases from Brazil. Arthritis Rheum 2011, 63:4007-4017.
54. Altiok E., Aksoy F., Perk Y., et al. Anovel mutation in the interleukin-1 receptor antagonist associated with intrauterine disease onset. Clin Immunol 2012, 145:77-81.
55. Schnellbacher C., Ciocca G., Menendez R., et al. Deficiency of interleukin-1 receptor antagonist responsive to anakinra. Pediatr Dermatol 2012, [Epub ahead of print].
56. Prose N.S., Fahrner L.J., Miller C.R., et al. Pustular psoriasis with chronic recurrent multifocal osteomyelitis and spontaneous fractures. JAm Acad Dermatol 1994, 31:376-379.
57. Stenerson M., Dufendach K., Aksentijevich I., et al. The first reported case of compound heterozygous IL1RN mutations causing deficiency of the interleukin-1 receptor antagonist. Arthritis Rheum 2011, 63:4018-4022.
58. Ter Haar N., Lachmann H., Ozen S., et al. Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis 2013, 72(5):678-685.
59. Ueki Y., Tiziani V., Santanna C., et al. Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism. Nat Genet 2001, 28:125-126.
60. Tiziani V., Reichenberger E., Buzzo C.L., et al. The gene for cherubism maps to chromosome 4p16. Am J Hum Genet 1999, 65:158-166.
61. Jones W.A., Gerrie J., Pritchard J. Cherubism: familial fibrous dysplasia of the jaws. JBone Joint Surg Br 1950, 32-B:334-347.
62. Mangion J., Rahman N., Edkins S., et al. The gene for cherubism maps to chromosome 4p16.3. Am J Hum Genet 1999, 65:151-157.
63. Reichenberger E.J., Levine M.A., Olsen B.R., et al. The role of SH3BP2 in the pathophysiology of cherubism. Orphanet J Rare Dis 2012, 7:S5.
64. Hero M., Suomalainen A., Hagström J., et al. Anti-tumor necrosis factor treatment in cherubism-clinical, radiological and histological findings in two children. Bone 2013, 52:347-353.
65. Pagnini I., Simonini G., Mortilla M., et al. Ineffectiveness of tumor necrosis factor-alpha inhibition in association with bisphosphonates for the treatment of cherubism. Clin Exp Rheumatol 2011, 29:147.
66. Chamot A.M., Benhamou C.L., Kahn M.F., et al. Acne-pustulosis-hyperostosis-osteitis syndrome: results of a national survey. 85 cases. Rev Rhum Mal Osteoartic 1987, 54:187-196.
67. Benhamou C.L., Chamot A.M., Kahn M.F. Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO): a new syndrome among the spondyloarthropathies?. Clin Exp Rheumatol 1988, 6:109-112.
68. Hurtado-Nedelec M., Chollet-Martin S., Chapeton D., et al. Genetic susceptibility factors in a cohort of 38 patients with SAPHO syndrome: a study of PSTPIP2, NOD2, and LPIN2 genes. JRheumatol 2010, 37:401-409.
69. Ferguson P.J., Lokuta M.A., El-Shanti H.I., et al. Neutrophil dysfunction in a family with a SAPHO syndrome-like phenotype. Arthritis Rheum 2008, 58:3264-3269.
70. Hurtado-Nedelec M., Chollet-Martin S., Nicaise-Roland P., et al. Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Rheumatology (Oxford) 2008, 47:1160-1167.
71. Ben Abdelghani K., Dran D.G., Gottenberg J.E., et al. Tumor necrosis factor-alpha blockers in SAPHO syndrome. JRheumatol 2010, 37:1699-1704.
72. Kerrison C., Davidson J.E., Cleary A.G., et al. Pamidronate in the treatment of childhood SAPHO syndrome. Rheumatology (Oxford) 2004, 43:1246-1251.
73. Kadom N., Egloff A., Obeid G., et al. Juvenile mandibular chronic osteomyelitis: multimodality imaging findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011, 111:e38-e43.